Skip to main content
Top
Published in: Breast Cancer 1/2012

01-01-2012 | Case Report

Successful perioperative management for a breast cancer patient with Bernard–Soulier syndrome

Authors: Riki Okita, Jun Hihara, Kazuo Konishi, Akihiko Osaki, Kingo Fujimura

Published in: Breast Cancer | Issue 1/2012

Login to get access

Abstract

We herein report the first case of a Bernard–Soulier syndrome (BSS) patient undergoing a surgical procedure for breast cancer. BSS is a rare hereditary thrombocytopathy associated with defects of the platelet glycoprotein complex glycoprotein Ib/V/IX and characterized by large platelets, thrombocytopenia, and severe bleeding symptoms. Because of the rarity of BSS, there are as yet no defined protocols for the perioperative management, which can be very complex and challenging in patients with coagulopathies, in particular BSS. In this case we successfully performed both an interventional examination as well as mastectomy with axillary lymph node dissection, under the preventive and intermittent transfusion of platelets. No intra- or postoperative bleeding complications occurred. Unfortunately, the patient was diagnosed as having metastatic disease involving liver, lungs, and bones 10 months after the surgery. She had received 1st, 2nd, and 3rd line chemotherapy without severe adverse events. However, gastrointestinal bleeding appeared after she was treated with 4th line chemotherapy. Finally, she succumbed 22 months after the breast surgery.
Literature
1.
go back to reference Bennett JS, Shattil SJ. Congenital qualitative platelet disorders. In: Williams WJ, Beutler E, Erslev AJ, editors. Hematology. 4th ed. New York: McGraw-Hill; 1990. p. 1407–19. Bennett JS, Shattil SJ. Congenital qualitative platelet disorders. In: Williams WJ, Beutler E, Erslev AJ, editors. Hematology. 4th ed. New York: McGraw-Hill; 1990. p. 1407–19.
2.
go back to reference Lopez JA, Andrews RK, Afshar-Kharghan V, Berndt MC. Bernard-Soulier syndrome. Blood. 1998;91:4397–418.PubMed Lopez JA, Andrews RK, Afshar-Kharghan V, Berndt MC. Bernard-Soulier syndrome. Blood. 1998;91:4397–418.PubMed
3.
go back to reference Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Büller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol. 2000;18:3078–83.PubMed Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Büller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol. 2000;18:3078–83.PubMed
4.
go back to reference Okita R, Hihara J, Konishi K, Osaki A, Yoshida K, Yamaguchi Y, et al. Intractable gastrointestinal bleeding from angiodysplasia in a patient of Bernard-Soulier syndrome—report of a case. Hiroshima J Med Sci. 2005;54:113–5.PubMed Okita R, Hihara J, Konishi K, Osaki A, Yoshida K, Yamaguchi Y, et al. Intractable gastrointestinal bleeding from angiodysplasia in a patient of Bernard-Soulier syndrome—report of a case. Hiroshima J Med Sci. 2005;54:113–5.PubMed
5.
go back to reference Sobin LH, Wittekind C. TNM classification of malignant tumors. 6th ed. New York: Wiley; 2002. p. 21–3. Sobin LH, Wittekind C. TNM classification of malignant tumors. 6th ed. New York: Wiley; 2002. p. 21–3.
6.
go back to reference Aisner J, Cirrincione C, Perloff M, Perry M, Budman D, Abrams J, et al. Combination chemotherapy for metastatic or recurrent carcinoma of the breast—a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281. J Clin Oncol. 1995;13:1443–52.PubMed Aisner J, Cirrincione C, Perloff M, Perry M, Budman D, Abrams J, et al. Combination chemotherapy for metastatic or recurrent carcinoma of the breast—a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281. J Clin Oncol. 1995;13:1443–52.PubMed
7.
go back to reference Bernard J, Soulier JP. Sur une nouvelle variété de dystrophie thrombocytaire-hémorragipare congenitate. Sem Hop Paris. 1948;24:3217–22.PubMed Bernard J, Soulier JP. Sur une nouvelle variété de dystrophie thrombocytaire-hémorragipare congenitate. Sem Hop Paris. 1948;24:3217–22.PubMed
8.
go back to reference Peters M, Heijboer H. Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa. Thromb Haemost. 1998;80:352.PubMed Peters M, Heijboer H. Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa. Thromb Haemost. 1998;80:352.PubMed
9.
go back to reference Kunishima S, Kamiya T, Saito H. Genetic abnormalities of Bernard-Soulier syndrome. Int J Hematol. 2002;76:319–27.PubMedCrossRef Kunishima S, Kamiya T, Saito H. Genetic abnormalities of Bernard-Soulier syndrome. Int J Hematol. 2002;76:319–27.PubMedCrossRef
10.
go back to reference Kunishima S, Imai T, Hamaguchi M, Saito H. Novel heterozygous missense mutation in the second leucine rich repeat of GPIbalpha affects GPIb/IX/V expression and results in macrothrombocytopenia in a patient initially misdiagnosed with idiopathic thrombocytopenic purpura. Eur J Haematol. 2006;76:348–55.PubMedCrossRef Kunishima S, Imai T, Hamaguchi M, Saito H. Novel heterozygous missense mutation in the second leucine rich repeat of GPIbalpha affects GPIb/IX/V expression and results in macrothrombocytopenia in a patient initially misdiagnosed with idiopathic thrombocytopenic purpura. Eur J Haematol. 2006;76:348–55.PubMedCrossRef
11.
go back to reference Girma JP, Meyer D, Verweij CL, Panneknoek H, Sixma JJ. Structure-function relationship of human von Willebrand factor. Blood. 1987;70:605–11.PubMed Girma JP, Meyer D, Verweij CL, Panneknoek H, Sixma JJ. Structure-function relationship of human von Willebrand factor. Blood. 1987;70:605–11.PubMed
12.
go back to reference Ruggeri ZM, Ware J. The structure and function of von Willebrand factor. Thromb Haemost. 1992;67:594–9.PubMed Ruggeri ZM, Ware J. The structure and function of von Willebrand factor. Thromb Haemost. 1992;67:594–9.PubMed
13.
go back to reference Humphries JE, Yirinec BA, Hess CE. Atherosclerosis and unstable angina in Bernard-Soulier syndrome. Am J Clin Pathol. 1992;97:652–5.PubMed Humphries JE, Yirinec BA, Hess CE. Atherosclerosis and unstable angina in Bernard-Soulier syndrome. Am J Clin Pathol. 1992;97:652–5.PubMed
14.
go back to reference Okamura T, Kanaji T, Osaki K, Kuroiwa M, Yamashita S, Niho Y. Gastrointestinal angiodysplasia in congenital platelet dysfunction. Int J Hematol. 1996;65:79–84.PubMedCrossRef Okamura T, Kanaji T, Osaki K, Kuroiwa M, Yamashita S, Niho Y. Gastrointestinal angiodysplasia in congenital platelet dysfunction. Int J Hematol. 1996;65:79–84.PubMedCrossRef
15.
go back to reference Yuksel O, Koklu S, Ucar E, Sasmaz N, Sahin B. Severe recurrent gastrointestinal bleeding due to angiodysplasia in a Bernard-Soulier patient. An onerous medical concomitance. Dig Dis Sci. 2004;49:885–7.PubMedCrossRef Yuksel O, Koklu S, Ucar E, Sasmaz N, Sahin B. Severe recurrent gastrointestinal bleeding due to angiodysplasia in a Bernard-Soulier patient. An onerous medical concomitance. Dig Dis Sci. 2004;49:885–7.PubMedCrossRef
16.
go back to reference Kostopanagiotou G, Siafaka I, Sikiotis C, Smyrniotis V. Anesthetic and perioperative management of a patient with Bernard-Soulier syndrome. J Clin Anesth. 2004;16:458–60.PubMedCrossRef Kostopanagiotou G, Siafaka I, Sikiotis C, Smyrniotis V. Anesthetic and perioperative management of a patient with Bernard-Soulier syndrome. J Clin Anesth. 2004;16:458–60.PubMedCrossRef
17.
go back to reference Bilal RH, Moideen I, Pyke L, Makahleh Z, Jimenez PF, Hasan R. Off-pump coronary artery bypass grafting in a patient with Bernard-Soulier syndrome. Ann Thorac Surg. 2010;90:284–5.PubMedCrossRef Bilal RH, Moideen I, Pyke L, Makahleh Z, Jimenez PF, Hasan R. Off-pump coronary artery bypass grafting in a patient with Bernard-Soulier syndrome. Ann Thorac Surg. 2010;90:284–5.PubMedCrossRef
18.
go back to reference Panzer S, Eichelberger B, Koren D, Kaufmann K, Male C. Monitoring survival and function of transfused platelets in Bernard-Soulier syndrome by flow cytometry and a cone and plate (let) analyzer (Impact-R). Transfusion. 2007;47:103–6.PubMedCrossRef Panzer S, Eichelberger B, Koren D, Kaufmann K, Male C. Monitoring survival and function of transfused platelets in Bernard-Soulier syndrome by flow cytometry and a cone and plate (let) analyzer (Impact-R). Transfusion. 2007;47:103–6.PubMedCrossRef
19.
go back to reference Hayward CP. Diagnosis and management of mild bleeding disorders. Hematology 2005:423–28. Hayward CP. Diagnosis and management of mild bleeding disorders. Hematology 2005:423–28.
20.
go back to reference Ozelo MC, Svirin P, Larina L. Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome. Ann Hematol. 2005;84:816–22.PubMedCrossRef Ozelo MC, Svirin P, Larina L. Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome. Ann Hematol. 2005;84:816–22.PubMedCrossRef
21.
go back to reference Cuthbert RJG, Watson HHK, Handa SI, Abbott I, Ludlam CA. DDAVP shorten the bleeding time in Bernard-Soulier syndrome. Thromb Res. 1988;49:649–50.PubMedCrossRef Cuthbert RJG, Watson HHK, Handa SI, Abbott I, Ludlam CA. DDAVP shorten the bleeding time in Bernard-Soulier syndrome. Thromb Res. 1988;49:649–50.PubMedCrossRef
22.
go back to reference Alamelu J, Liesner R. Modern management of severe platelet function disorders. Br J Haematol. 2010;149:813–23.PubMedCrossRef Alamelu J, Liesner R. Modern management of severe platelet function disorders. Br J Haematol. 2010;149:813–23.PubMedCrossRef
Metadata
Title
Successful perioperative management for a breast cancer patient with Bernard–Soulier syndrome
Authors
Riki Okita
Jun Hihara
Kazuo Konishi
Akihiko Osaki
Kingo Fujimura
Publication date
01-01-2012
Publisher
Springer Japan
Published in
Breast Cancer / Issue 1/2012
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-010-0241-6

Other articles of this Issue 1/2012

Breast Cancer 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine